Paid Clinical Trials in Lake Success, NY
As of July 2026, 146 paid clinical trials are recruiting in Lake Success, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Lake Success offers studies at sites including Northwell Health/Center for Advanced Medicine for conditions such as Advanced Solid Tumors, Colorectal Cancer, Endometrial Cancer, Head and Neck Squamous Cell Carcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Lake Success
Trials by drug in Lake Success
Filter results
Newly added in Lake Success
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Study of NTB-928 in R/R OC
136 clinical trials
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
The PREDICT Registry:
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
Top Research Study Locations in Lake Success
Researchers run research studies in Lake Success, NY at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Northwell Health/Center for Advanced Medicine | Anatomic Stage II Breast Cancer AJCC v8, Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 | 39 |
| Northwell Health | Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, 1st Line NSCLC | 15 |
| Northwell Health Cancer Institute | Acinar Cell Carcinoma, Advanced Cancer, Advanced Melanoma | 7 |
| Northwell Health/ RJ Zuckerberg Cancer Center | Neoplasm Metastasis, Advanced Solid Tumors, Carcinoma, Non-Small-Cell Lung | 6 |
| START New York | Advanced Solid Tumor, Advanced Solid Tumors, Endometrial Adenocarcinoma | 5 |
| GSK Investigational Site | Breast Neoplasms, Gastrointestinal Neoplasms, Neoplasms | 3 |
| Northwell Health Center for Advanced Medicine. | Colorectal Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer | 3 |
| Northwell Health -The Arthur Smith Institute for Urology | Intermediate Risk Non-Muscle Invasive Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ | 2 |
| Northwell Health Long Island Jewish Medical Center | Arterial Disease of Legs, Below-the-knee Obstruction, Chronic Limb-Threatening Ischemia | 2 |
| Northwell Health, LLC PRIME | AML, AML With Mutated NPM1, Acute Leukemia | 2 |
| Northwell Health, R.J. Zuckerberg Cancer Center | Advanced Melanoma, MF, Myelofibrosis | 2 |
| Northwell Health/R.J. Zuckerberg Cancer Center | Advanced Non-Small-Cell Lung Cancer, EGFR P-Loop and Alpha C-Helix Compressing, EGFR PACC | 2 |
| RJ Zuckerberg | Colorectal Cancer Metastatic | 2 |
| START New York Long Island | Head and Neck Squamous Cell Carcinoma, Advanced Solid Tumor, Cutaneous Squamous Cell Carcinoma | 2 |
| START New York Long Island, LLC | Castration-resistant Prostate Cancer, Castration-resistant Prostate Cancer (CRPC), Colorectal Cancer | 2 |
| Ascendis Pharma Investigational Site | Idiopathic Short Stature, Short Stature Homeobox Gene Mutation, Small for Gestational Age at Delivery | 1 |
| Clincial Research | Non-healing Wound, Venous Insufficiency of Leg, Venous Leg Ulcer | 1 |
| Clinical Research Alliance, Inc | Small Cell Lung Cancer | 1 |
| Cohen Children's Medical Center | Cardiomyopathy | 1 |
| Cohen Children's Medical Center - Lakeville Road | Cystic Fibrosis | 1 |
| Cohen Children's Medical Center of NY | Crohn Disease | 1 |
| Cohen Children's Medical Center of New York | Rheumatic Joint Disease | 1 |
| Comprehensive Wound Healing Center, Northwell Health | Diabetic Foot Ulcer, Venous Leg Ulcer | 1 |
| Cynthia Knauer | Magnetic Resonance Imaging, Population at Risk, Prostate Cancer | 1 |
| Dermatology at Lake Success | Pyoderma Gangrenosum | 1 |
Active & Upcoming Studies in Lake Success (2026)
Recruiting trials in Lake Success grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (96 active studies)
- Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer · Phase 1 · Evopoint Biosciences Inc.
- KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line) · Phase 2 · Kumquat Biosciences Inc.
Diabetes & metabolic (2 active studies)
- A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events · Cleerly, Inc.
- DFC 004 Biomarkers for Active Diabetic Foot Ulcers · University of Michigan
Neurology & pain (2 active studies)
- Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS · Phase 2 · Vaneltix Pharma, Inc.
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Cardiovascular (1 active study)
- Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting · Philips Clinical & Medical Affairs Global
Pediatric (1 active study)
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Common conditions studied in Lake Success
- Advanced Solid Tumors (6 active studies)
- Colorectal Cancer (6 active studies)
- Endometrial Cancer (5 active studies)
- Head and Neck Squamous Cell Carcinoma (5 active studies)
- Advanced Solid Tumor (4 active studies)
- Non Small Cell Lung Cancer (4 active studies)
Leading research sponsors in Lake Success
- NRG Oncology
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- Northwell Health
- AbbVie
Frequently asked questions
How many paid clinical trials are currently recruiting in Lake Success?
There are approximately 146 recruiting clinical trials in Lake Success, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Lake Success pay participants?
Most recruiting trials in Lake Success compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Lake Success?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Lake Success?
The most common conditions under active study in Lake Success include Advanced Solid Tumors (6), Colorectal Cancer (6), Endometrial Cancer (5), Head and Neck Squamous Cell Carcinoma (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Lake Success?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lake Success on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Lake Success?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Lake Success?
Recruiting research sites in Lake Success include Northwell Health/Center for Advanced Medicine, Northwell Health, Northwell Health Cancer Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Lake Success right now?
The largest active categories in Lake Success are Cancer & tumors (96), Diabetes & metabolic (2), Neurology & pain (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.